Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-11-23
pubmed:abstractText
No currently available treatment provides consistent relief of irritable bowel syndrome. Colonic sensory and motor function are modulated partly through 5HT3-receptors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0269-2813
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1149-59
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10468696-Abdominal Pain, pubmed-meshheading:10468696-Adult, pubmed-meshheading:10468696-Canada, pubmed-meshheading:10468696-Carbolines, pubmed-meshheading:10468696-Colonic Diseases, Functional, pubmed-meshheading:10468696-Diarrhea, pubmed-meshheading:10468696-Dose-Response Relationship, Drug, pubmed-meshheading:10468696-Double-Blind Method, pubmed-meshheading:10468696-Female, pubmed-meshheading:10468696-Germany, pubmed-meshheading:10468696-Great Britain, pubmed-meshheading:10468696-Humans, pubmed-meshheading:10468696-Male, pubmed-meshheading:10468696-Middle Aged, pubmed-meshheading:10468696-Netherlands, pubmed-meshheading:10468696-Serotonin Antagonists, pubmed-meshheading:10468696-Sex Factors, pubmed-meshheading:10468696-Treatment Outcome, pubmed-meshheading:10468696-United States
pubmed:year
1999
pubmed:articleTitle
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.
pubmed:affiliation
Gastroenterology Research Unit, Mayo Foundation, Rochester, Minnesota 55905, USA. camilleri.michael@mayol.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study